| 0 |
UTERINE FISTULA |
1 |
0.0303 |
| 1 |
PRODUCT DIFFICULT TO REMOVE |
1 |
0.0167 |
| 2 |
NASAL SEPTUM ULCERATION |
1 |
0.0161 |
| 3 |
MALIGNANT MESENTERIC NEOPLASM |
1 |
0.0132 |
| 4 |
RETINOSCHISIS |
1 |
0.0072 |
| 5 |
PINEAL GLAND CYST |
1 |
0.0071 |
| 6 |
NEUROSYPHILIS |
1 |
0.0066 |
| 7 |
CAROTID ARTERY DISSECTION |
2 |
0.0047 |
| 8 |
KLEBSIELLA URINARY TRACT INFECTION |
1 |
0.0038 |
| 9 |
ARTERIOVENOUS FISTULA OPERATION |
1 |
0.0037 |
| 10 |
BACTERIAL TEST |
1 |
0.0034 |
| 11 |
VAGINAL LESION |
1 |
0.0033 |
| 12 |
ARTERIOVENOUS FISTULA THROMBOSIS |
1 |
0.0029 |
| 13 |
TUMOUR RUPTURE |
1 |
0.0018 |
| 14 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
1 |
0.0017 |
| 15 |
NASAL SEPTUM PERFORATION |
1 |
0.0015 |
| 16 |
PRODUCT PACKAGE ASSOCIATED INJURY |
3 |
0.0013 |
| 17 |
SEIZURE CLUSTER |
1 |
0.0012 |
| 18 |
STARVATION |
1 |
0.0012 |
| 19 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 20 |
BLADDER CATHETERISATION |
1 |
0.0010 |
| 21 |
PRODUCT BLISTER PACKAGING ISSUE |
1 |
0.0010 |
| 22 |
CHRONIC SPONTANEOUS URTICARIA |
1 |
0.0009 |
| 23 |
NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0008 |
| 24 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
2 |
0.0008 |
| 25 |
PREGNANCY ON ORAL CONTRACEPTIVE |
2 |
0.0008 |
| 26 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 27 |
METRORRHAGIA |
12 |
0.0007 |
| 28 |
HAEMORRHAGE IN PREGNANCY |
1 |
0.0007 |
| 29 |
PREGNANCY ON CONTRACEPTIVE |
1 |
0.0007 |
| 30 |
PULMONARY VALVE INCOMPETENCE |
1 |
0.0007 |
| 31 |
GASTROSTOMY |
1 |
0.0006 |
| 32 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 33 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 34 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 35 |
CONTRAINDICATED PRODUCT PRESCRIBED |
1 |
0.0006 |
| 36 |
EXPOSURE TO SARS-COV-2 |
1 |
0.0006 |
| 37 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 38 |
UTERINE SPASM |
1 |
0.0005 |
| 39 |
CYSTIC FIBROSIS |
3 |
0.0005 |
| 40 |
WHITE BLOOD CELLS URINE POSITIVE |
1 |
0.0005 |
| 41 |
MYELOPATHY |
1 |
0.0005 |
| 42 |
VASCULAR STENT THROMBOSIS |
1 |
0.0005 |
| 43 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 44 |
DEREALISATION |
1 |
0.0005 |
| 45 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 46 |
MENORRHAGIA |
9 |
0.0005 |
| 47 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 48 |
UTERINE LEIOMYOMA |
3 |
0.0004 |
| 49 |
VASODILATATION |
1 |
0.0004 |
| 50 |
AMMONIA INCREASED |
2 |
0.0004 |
| 51 |
ABNORMAL UTERINE BLEEDING |
1 |
0.0004 |
| 52 |
ANAL FISTULA |
2 |
0.0004 |
| 53 |
ANAL ABSCESS |
2 |
0.0004 |
| 54 |
HYPOMENORRHOEA |
1 |
0.0004 |
| 55 |
RHINALGIA |
1 |
0.0004 |
| 56 |
LUNG CONSOLIDATION |
1 |
0.0004 |
| 57 |
SKIN SWELLING |
3 |
0.0003 |
| 58 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 59 |
ACNE CYSTIC |
1 |
0.0003 |
| 60 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 61 |
HEPATIC NEOPLASM |
1 |
0.0003 |
| 62 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 63 |
THROMBOSIS IN DEVICE |
1 |
0.0003 |
| 64 |
SUSPECTED COVID-19 |
1 |
0.0003 |
| 65 |
PEPTIC ULCER |
1 |
0.0003 |
| 66 |
TONGUE ULCERATION |
1 |
0.0003 |
| 67 |
POLYMENORRHOEA |
1 |
0.0003 |
| 68 |
HANGOVER |
1 |
0.0003 |
| 69 |
INTERCEPTED PRODUCT STORAGE ERROR |
1 |
0.0003 |
| 70 |
ASTHMATIC CRISIS |
1 |
0.0003 |
| 71 |
HEPATOCELLULAR CARCINOMA |
2 |
0.0003 |
| 72 |
WOUND SECRETION |
1 |
0.0003 |
| 73 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 74 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 75 |
RECURRENT CANCER |
1 |
0.0002 |
| 76 |
HYPERURICAEMIA |
1 |
0.0002 |
| 77 |
HORDEOLUM |
1 |
0.0002 |
| 78 |
HEAVY MENSTRUAL BLEEDING |
2 |
0.0002 |
| 79 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 80 |
YELLOW SKIN |
1 |
0.0002 |
| 81 |
VAGINAL INFECTION |
1 |
0.0002 |
| 82 |
PRODUCT PACKAGING ISSUE |
2 |
0.0002 |
| 83 |
ENDOMETRIOSIS |
1 |
0.0002 |
| 84 |
RASH VESICULAR |
1 |
0.0002 |
| 85 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 86 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 87 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 88 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 89 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 90 |
INTESTINAL RESECTION |
1 |
0.0002 |
| 91 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 92 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 93 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 94 |
VENTRICULAR SEPTAL DEFECT |
1 |
0.0002 |
| 95 |
METABOLIC DISORDER |
1 |
0.0002 |
| 96 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 97 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 98 |
PRODUCT DOSE OMISSION |
11 |
0.0002 |
| 99 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 100 |
DRUG DIVERSION |
1 |
0.0002 |
| 101 |
VAGINAL HAEMORRHAGE |
7 |
0.0002 |
| 102 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 103 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 104 |
SLEEP APNOEA SYNDROME |
3 |
0.0002 |
| 105 |
CARDIAC FLUTTER |
1 |
0.0002 |
| 106 |
DERMATITIS ATOPIC |
8 |
0.0002 |
| 107 |
DYSMENORRHOEA |
2 |
0.0002 |
| 108 |
BRONCHIECTASIS |
1 |
0.0001 |
| 109 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 110 |
SINUS CONGESTION |
2 |
0.0001 |
| 111 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 112 |
ONYCHOCLASIS |
1 |
0.0001 |
| 113 |
DIVERTICULUM |
1 |
0.0001 |
| 114 |
METASTASIS |
1 |
0.0001 |
| 115 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 116 |
PANIC REACTION |
1 |
0.0001 |
| 117 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 118 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 119 |
ARTHROPOD BITE |
1 |
0.0001 |
| 120 |
BREAST TENDERNESS |
1 |
0.0001 |
| 121 |
DISSOCIATION |
1 |
0.0001 |
| 122 |
APNOEA |
1 |
0.0001 |
| 123 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 124 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 125 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 126 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 127 |
PRODUCT SUBSTITUTION ISSUE |
7 |
0.0001 |
| 128 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 129 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 130 |
THERAPY CESSATION |
6 |
0.0001 |
| 131 |
CARDIAC OPERATION |
1 |
0.0001 |
| 132 |
AMENORRHOEA |
2 |
0.0001 |
| 133 |
THIRST |
2 |
0.0001 |
| 134 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 135 |
HIDRADENITIS |
1 |
0.0001 |
| 136 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 137 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 138 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 139 |
EMBEDDED DEVICE |
1 |
0.0001 |
| 140 |
HYPOTONIA |
1 |
0.0001 |
| 141 |
OVARIAN CYST |
1 |
0.0001 |
| 142 |
BRAIN INJURY |
1 |
0.0001 |
| 143 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 144 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 145 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 146 |
ECZEMA |
5 |
0.0001 |
| 147 |
MOOD SWINGS |
3 |
0.0001 |
| 148 |
BREAST PAIN |
1 |
0.0001 |
| 149 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 150 |
SKIN LACERATION |
1 |
0.0001 |
| 151 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 152 |
TOOTH FRACTURE |
1 |
0.0001 |
| 153 |
THERAPEUTIC RESPONSE SHORTENED |
3 |
0.0001 |
| 154 |
PRODUCT USE IN UNAPPROVED INDICATION |
22 |
0.0001 |
| 155 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 156 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 157 |
MICTURITION URGENCY |
1 |
0.0001 |
| 158 |
MULTIPLE SCLEROSIS RELAPSE |
6 |
0.0001 |
| 159 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 160 |
METASTASES TO LUNG |
1 |
0.0001 |
| 161 |
EYELID OEDEMA |
1 |
0.0001 |
| 162 |
NOCTURIA |
1 |
0.0001 |
| 163 |
DISCOMFORT |
5 |
0.0001 |
| 164 |
SPINAL OPERATION |
1 |
0.0001 |
| 165 |
CYST |
1 |
0.0001 |
| 166 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 167 |
EXPOSURE VIA SKIN CONTACT |
2 |
0.0001 |
| 168 |
SPEECH DISORDER |
4 |
0.0001 |
| 169 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 170 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 171 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 172 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 173 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 174 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 175 |
DIVERTICULITIS |
2 |
0.0001 |
| 176 |
POLLAKIURIA |
3 |
0.0001 |
| 177 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 178 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 179 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 180 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 181 |
APATHY |
1 |
0.0001 |
| 182 |
DYSSTASIA |
2 |
0.0001 |
| 183 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 184 |
THYROID DISORDER |
1 |
0.0001 |
| 185 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 186 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 187 |
OBESITY |
1 |
0.0001 |
| 188 |
ABSCESS |
1 |
0.0001 |
| 189 |
NIGHT SWEATS |
2 |
0.0001 |
| 190 |
PERICARDITIS |
1 |
0.0001 |
| 191 |
SLEEP DISORDER |
4 |
0.0001 |
| 192 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 193 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 194 |
PELVIC PAIN |
1 |
0.0001 |
| 195 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 196 |
PRODUCT USE ISSUE |
10 |
0.0001 |
| 197 |
ACNE |
4 |
0.0001 |
| 198 |
INCREASED APPETITE |
1 |
0.0001 |
| 199 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 200 |
SURGERY |
3 |
0.0001 |
| 201 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 202 |
SINUS DISORDER |
1 |
0.0001 |
| 203 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 204 |
THROMBOSIS |
4 |
0.0000 |
| 205 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 206 |
FEEDING DISORDER |
1 |
0.0000 |
| 207 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 208 |
DERMATITIS |
1 |
0.0000 |
| 209 |
EATING DISORDER |
1 |
0.0000 |
| 210 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 211 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 212 |
RHINORRHOEA |
3 |
0.0000 |
| 213 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 214 |
PSORIASIS |
6 |
0.0000 |
| 215 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 216 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 217 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 218 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 219 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 220 |
MEMORY IMPAIRMENT |
6 |
0.0000 |
| 221 |
MUSCLE SPASMS |
8 |
0.0000 |
| 222 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 223 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 224 |
MIGRAINE |
4 |
0.0000 |
| 225 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 226 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 227 |
LIVER INJURY |
1 |
0.0000 |
| 228 |
WEIGHT INCREASED |
9 |
0.0000 |
| 229 |
DRY EYE |
2 |
0.0000 |
| 230 |
HOT FLUSH |
3 |
0.0000 |
| 231 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 232 |
FLUSHING |
4 |
0.0000 |
| 233 |
PRURITUS |
15 |
0.0000 |
| 234 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 235 |
NO ADVERSE EVENT |
7 |
0.0000 |
| 236 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 237 |
HAEMORRHAGE |
4 |
0.0000 |
| 238 |
SEDATION |
1 |
0.0000 |
| 239 |
JOINT STIFFNESS |
1 |
0.0000 |
| 240 |
EAR INFECTION |
1 |
0.0000 |
| 241 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 242 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 243 |
RASH PRURITIC |
2 |
0.0000 |
| 244 |
PNEUMONITIS |
1 |
0.0000 |
| 245 |
MOOD ALTERED |
1 |
0.0000 |
| 246 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 247 |
ASTHMA |
4 |
0.0000 |
| 248 |
HYPERSOMNIA |
1 |
0.0000 |
| 249 |
SEIZURE |
4 |
0.0000 |
| 250 |
NEEDLE ISSUE |
1 |
0.0000 |
| 251 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 252 |
NASAL CONGESTION |
2 |
0.0000 |
| 253 |
TACHYCARDIA |
3 |
0.0000 |
| 254 |
WHEEZING |
2 |
0.0000 |
| 255 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 256 |
IRRITABILITY |
2 |
0.0000 |
| 257 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 258 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 259 |
EPILEPSY |
1 |
0.0000 |
| 260 |
BLOOD PRESSURE INCREASED |
5 |
0.0000 |
| 261 |
INJECTION SITE RASH |
1 |
0.0000 |
| 262 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 263 |
HEAD INJURY |
1 |
0.0000 |
| 264 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 265 |
ALOPECIA |
6 |
0.0000 |
| 266 |
URINARY RETENTION |
1 |
0.0000 |
| 267 |
DRY SKIN |
4 |
0.0000 |
| 268 |
URTICARIA |
5 |
0.0000 |
| 269 |
EYE PRURITUS |
1 |
0.0000 |
| 270 |
SINUSITIS |
3 |
0.0000 |
| 271 |
RASH MACULAR |
1 |
0.0000 |
| 272 |
BURNING SENSATION |
2 |
0.0000 |
| 273 |
COVID-19 |
5 |
0.0000 |
| 274 |
HYPOXIA |
1 |
0.0000 |
| 275 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 276 |
CRYING |
1 |
0.0000 |
| 277 |
PANIC ATTACK |
1 |
0.0000 |
| 278 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 279 |
RESTLESSNESS |
1 |
0.0000 |
| 280 |
INJECTION SITE MASS |
1 |
0.0000 |
| 281 |
INFLUENZA |
3 |
0.0000 |
| 282 |
DYSARTHRIA |
1 |
0.0000 |
| 283 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 284 |
COLITIS |
1 |
0.0000 |
| 285 |
DEPRESSION |
6 |
0.0000 |
| 286 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 287 |
PARAESTHESIA |
4 |
0.0000 |
| 288 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 289 |
RASH |
11 |
0.0000 |
| 290 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 291 |
DYSKINESIA |
1 |
0.0000 |
| 292 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 293 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 294 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 295 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 296 |
BALANCE DISORDER |
2 |
0.0000 |
| 297 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 298 |
MENTAL DISORDER |
1 |
0.0000 |
| 299 |
CONSTIPATION |
5 |
0.0000 |
| 300 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 301 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 302 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 303 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 304 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 305 |
PNEUMONIA |
7 |
0.0000 |
| 306 |
NAUSEA |
17 |
0.0000 |
| 307 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 308 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 309 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 310 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 311 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 312 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 313 |
HEADACHE |
13 |
0.0000 |
| 314 |
HEART RATE INCREASED |
2 |
0.0000 |
| 315 |
HOSPITALISATION |
3 |
0.0000 |
| 316 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 317 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 318 |
INFLAMMATION |
1 |
0.0000 |
| 319 |
NERVOUSNESS |
1 |
0.0000 |
| 320 |
DIARRHOEA |
12 |
0.0000 |
| 321 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 322 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 323 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 324 |
TREMOR |
3 |
0.0000 |
| 325 |
ARTHROPATHY |
1 |
0.0000 |
| 326 |
BLISTER |
1 |
0.0000 |
| 327 |
HERPES ZOSTER |
1 |
0.0000 |
| 328 |
LETHARGY |
1 |
0.0000 |
| 329 |
EYE IRRITATION |
1 |
0.0000 |
| 330 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 331 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 332 |
STOMATITIS |
1 |
0.0000 |
| 333 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 334 |
FEELING HOT |
1 |
0.0000 |
| 335 |
CHEST PAIN |
3 |
0.0000 |
| 336 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 337 |
DYSPNOEA |
9 |
0.0000 |
| 338 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 339 |
AMNESIA |
1 |
0.0000 |
| 340 |
DEHYDRATION |
2 |
0.0000 |
| 341 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 342 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 343 |
SOMNOLENCE |
3 |
0.0000 |
| 344 |
VOMITING |
7 |
0.0000 |
| 345 |
ERYTHEMA |
3 |
0.0000 |
| 346 |
PYREXIA |
5 |
0.0000 |
| 347 |
COUGH |
4 |
0.0000 |
| 348 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 349 |
INJURY |
1 |
0.0000 |
| 350 |
HYPERTENSION |
3 |
0.0000 |
| 351 |
FATIGUE |
11 |
0.0000 |
| 352 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 353 |
INFECTION |
2 |
0.0000 |
| 354 |
BRONCHITIS |
1 |
0.0000 |
| 355 |
DYSGEUSIA |
1 |
0.0000 |
| 356 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 357 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 358 |
BACK PAIN |
3 |
0.0000 |
| 359 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 360 |
ARTHRITIS |
1 |
0.0000 |
| 361 |
FEELING ABNORMAL |
3 |
0.0000 |
| 362 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 363 |
CARDIAC ARREST |
1 |
0.0000 |
| 364 |
FALL |
4 |
0.0000 |
| 365 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 366 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 367 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 368 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 369 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 370 |
INSOMNIA |
3 |
0.0000 |
| 371 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 372 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 373 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 374 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 375 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 376 |
WEIGHT DECREASED |
3 |
0.0000 |
| 377 |
CARDIAC DISORDER |
1 |
0.0000 |
| 378 |
DYSPHAGIA |
1 |
0.0000 |
| 379 |
DYSPEPSIA |
1 |
0.0000 |
| 380 |
DRUG INEFFECTIVE |
13 |
0.0000 |
| 381 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 382 |
ILLNESS |
1 |
0.0000 |
| 383 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 384 |
OFF LABEL USE |
8 |
0.0000 |
| 385 |
SEPSIS |
1 |
0.0000 |
| 386 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 387 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 388 |
PAIN |
5 |
0.0000 |
| 389 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 390 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 391 |
ANXIETY |
2 |
0.0000 |
| 392 |
MALAISE |
3 |
0.0000 |
| 393 |
HYPOAESTHESIA |
1 |
0.0000 |
| 394 |
DIZZINESS |
3 |
0.0000 |
| 395 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 396 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 397 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 398 |
ARTHRALGIA |
2 |
0.0000 |
| 399 |
OVERDOSE |
1 |
0.0000 |
| 400 |
DECREASED APPETITE |
1 |
0.0000 |
| 401 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 402 |
DEATH |
1 |
0.0000 |